These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8058141)

  • 1. Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration.
    Gidal B; Spencer N; Maly M; Pitterle M; Williams E; Collins M; Jones J
    Neurology; 1994 Aug; 44(8):1418-22. PubMed ID: 8058141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic administration of valproic acid to epileptic patients on coagulation tests and primary hemostasis.
    Zighetti ML; Fontana G; Lussana F; Chiesa V; Vignoli A; Canevini MP; Cattaneo M
    Epilepsia; 2015 May; 56(5):e49-52. PubMed ID: 25757394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet count and function in children receiving sodium valproate.
    Verrotti A; Greco R; Matera V; Altobelli E; Morgese G; Chiarelli F
    Pediatr Neurol; 1999 Sep; 21(3):611-4. PubMed ID: 10513686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation abnormalities and acquired von Willebrand's disease type 1 in children receiving valproic acid.
    Serdaroglu G; Tütüncüoglu S; Kavakli K; Tekgül H
    J Child Neurol; 2002 Jan; 17(1):41-3. PubMed ID: 11913569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombocytopenia during valproic acid treatment in young patients with new-onset bipolar disorder.
    De Berardis D; Campanella D; Matera V; Gambi F; La Rovere R; Sepede G; Grimaldi MR; Pacilli AM; Salerno RM; Ferro FM
    J Clin Psychopharmacol; 2003 Oct; 23(5):451-8. PubMed ID: 14520121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate-induced thrombocytopenia: a prospective monotherapy study.
    Nasreddine W; Beydoun A
    Epilepsia; 2008 Mar; 49(3):438-45. PubMed ID: 18031547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate treatment and platelet function: the role of arachidonate metabolites.
    Kis B; Szupera Z; Mezei Z; Gecse A; Telegdy G; Vécsei L
    Epilepsia; 1999 Mar; 40(3):307-10. PubMed ID: 10080510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of valproate monotherapy on platelet activation and hematologic values.
    Zeller JA; Schlesinger S; Runge U; Kessler C
    Epilepsia; 1999 Feb; 40(2):186-9. PubMed ID: 9952265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid and thrombocytopenia in children: a case-controlled retrospective study.
    Allarakhia IN; Garofalo EA; Komarynski MA; Robertson PL
    Pediatr Neurol; 1996 May; 14(4):303-7. PubMed ID: 8805173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of nimesulide versus placebo on hemostasis in healthy volunteers.
    Marbet GA; Yasikoff Strub ML; Macciocchi A; Tsakiris DA
    Eur J Clin Pharmacol; 1998 Jul; 54(5):383-7. PubMed ID: 9754980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total steroidal alkaloids from Veratrum patulum L. Inhibit platelet aggregation, thrombi formation and decrease bleeding time in rats.
    Song Q; Wang S; Zhao W
    J Ethnopharmacol; 2012 May; 141(1):183-6. PubMed ID: 22366682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study.
    Koenig S; Gerstner T; Keller A; Teich M; Longin E; Dempfle CE
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):375-82. PubMed ID: 18600085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of erythropoietin on platelet serotonin storage and platelet aggregation in hemodialysis patients with reference to ketanserin treatment.
    Borawski J; Rydzewski A; Pawlak K; Azzadin A; Buczko W; Mysliwiec M
    Thromb Res; 1998 May; 90(4):171-80. PubMed ID: 9692616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate therapy induces von Willebrand disease type I.
    Kreuz W; Linde R; Funk M; Meyer-Schrod R; Föll E; Nowak-Göttl U; Jacobi G; Vigh Z; Scharrer I
    Epilepsia; 1992; 33(1):178-84. PubMed ID: 1733754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased platelet count in children with epilepsy treated with valproate and its relationship to the immature platelet fraction.
    Kurahashi H; Takami A; Murotani K; Numoto S; Okumura A
    Int J Hematol; 2018 Jan; 107(1):105-111. PubMed ID: 28879549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative valproate administration does not increase blood loss during temporal lobectomy.
    Ward MM; Barbaro NM; Laxer KD; Rampil IJ
    Epilepsia; 1996 Jan; 37(1):98-101. PubMed ID: 8603633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment.
    Anderson GD; Lin YX; Berge C; Ojemann GA
    J Neurosurg; 1997 Aug; 87(2):252-6. PubMed ID: 9254089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemostatic abnormalities in treatment-naïve patients with Type 1 Gaucher's disease.
    Mitrovic M; Antic D; Elezovic I; Janic D; Miljic P; Sumarac Z; Nikolic T; Suvajdzic N
    Platelets; 2012; 23(2):143-9. PubMed ID: 21767238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro- and anticoagulatory factors under sodium valproate-therapy in children.
    Banerjea MC; Diener W; Kutschke G; Schneble HJ; Korinthenberg R; Sutor AH
    Neuropediatrics; 2002 Aug; 33(4):215-20. PubMed ID: 12368993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.